Refsum disease
Refsum disease is a rare, autosomal recessive genetic disorder that affects the metabolism of phytanic acid, a type of fatty acid. It is characterized by the accumulation of phytanic acid in the blood and tissues, leading to a variety of symptoms.
Pathophysiology[edit | edit source]
Refsum disease is caused by mutations in the PHYH gene or the PEX7 gene. These genes are responsible for the breakdown of phytanic acid. When these genes are mutated, phytanic acid accumulates in the body, leading to the symptoms of the disease.
Symptoms[edit | edit source]
The symptoms of Refsum disease can vary widely but often include:
- Retinitis pigmentosa, leading to progressive vision loss
- Peripheral neuropathy, causing muscle weakness and numbness
- Cerebellar ataxia, resulting in coordination problems
- Hearing loss
- Ichthyosis, a skin condition characterized by dry, scaly skin
- Cardiomyopathy, affecting the heart muscle
Diagnosis[edit | edit source]
Diagnosis of Refsum disease typically involves:
- Blood tests to measure levels of phytanic acid
- Genetic testing to identify mutations in the PHYH or PEX7 genes
- Clinical evaluation of symptoms
Treatment[edit | edit source]
There is no cure for Refsum disease, but treatment focuses on managing symptoms and reducing phytanic acid levels. This can include:
- Dietary restrictions to limit intake of phytanic acid
- Plasmapheresis to remove phytanic acid from the blood
- Management of specific symptoms, such as vision aids for retinitis pigmentosa or physical therapy for peripheral neuropathy
Prognosis[edit | edit source]
The prognosis for individuals with Refsum disease varies. Early diagnosis and management can improve quality of life and reduce the risk of complications. However, the disease is progressive, and symptoms may worsen over time.
Related Pages[edit | edit source]
- Genetic disorder
- Autosomal recessive inheritance
- Fatty acid metabolism
- Retinitis pigmentosa
- Peripheral neuropathy
- Cerebellar ataxia
- Ichthyosis
- Cardiomyopathy
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD